ELII: CORE B - Therapeutics Targeting Filoviral interferon-antagonist and replication function

Project: Other project

StatusFinished
Effective start/end date3/1/1411/30/16

Funding

  • Icahn School of Medicine at Mount Sinai: $351,255.08